Johnson & Johnson (JNJ) Announces RYBREVANT plus LAZCLUZE approved in the U.S.

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. PSKY
2. META
3. NVDA
4. LGND
5. SPY
6. MONC:IM
7. PTON
8. NYXH
9. MONRY
10. PNR

Go back to Johnson & Johnson (JNJ) Announces RYBREVANT plus LAZCLUZE approved in the U.S.
Johnson & Johnson (NYSE: JNJ) Delayed: 269.47 --0 (-0%)
Previous Close $269.47    52 Week High $126.07 
Open $269.47    52 Week Low $94.28 
Day High $269.47    P/E 56.02 
Day Low $269.47    EPS $4.81 
Volume 8,103